Inspiremd Stock Today
| NSPR Stock | USD 2.01 0.06 3.08% |
Performance0 of 100
| Odds Of DistressLess than 9
|
InspireMD is selling at 2.01 as of the 3rd of May 2024; that is 3.08% increase since the beginning of the trading day. The stock's lowest day price was 1.95. InspireMD has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for InspireMD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of October 2022 and ending today, the 3rd of May 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 12th of April 2011 | Category Healthcare | Classification Health Care |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company has 23.42 M outstanding shares of which 92.69 K shares are now shorted by private and institutional investors with about 1.3 trading days to cover. More on InspireMD
Moving together with InspireMD Stock
| 0.84 | HUM | Humana Inc Financial Report 7th of August 2024 | PairCorr |
Moving against InspireMD Stock
| 0.82 | ELV | Elevance Health Financial Report 17th of July 2024 | PairCorr |
| 0.8 | GCTK | GlucoTrack | PairCorr |
| 0.78 | CI | Cigna Corp | PairCorr |
| 0.76 | MCK | McKesson Earnings Call This Week | PairCorr |
| 0.71 | DXR | Daxor | PairCorr |
| 0.63 | OMI | Owens Minor Earnings Call Today | PairCorr |
| 0.59 | ELYM | Eliem Therapeutics Trending | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 20th of May 2024
InspireMD Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. InspireMD's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding InspireMD or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Marvin Slosman | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering InspireMD report their recommendations after researching InspireMD's financial statements, talking to executives and customers, or listening in on InspireMD's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering InspireMD. The InspireMD consensus assessment is calculated by taking the average forecast from all of the analysts covering InspireMD. | |||||
InspireMD's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to InspireMD's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand InspireMD's financial leverage. It provides some insight into what part of InspireMD's total assets is financed by creditors.
| |||||
InspireMD (NSPR) is traded on NASDAQ Exchange in USA. It is located in 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 and employs 65 people. InspireMD is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 47.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate InspireMD's market, we take the total number of its shares issued and multiply it by InspireMD's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. InspireMD conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 23.42 M outstanding shares of which 92.69 K shares are now shorted by private and institutional investors with about 1.3 trading days to cover.
InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check InspireMD Probability Of Bankruptcy
Ownership AllocationInspireMD secures a total of 23.42 Million outstanding shares. 30% of InspireMD outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check InspireMD Ownership Details
InspireMD Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of InspireMD jumping above the current price in 90 days from now is about 92.62%. The InspireMD probability density function shows the probability of InspireMD stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days InspireMD has a beta of 0.9564. This indicates InspireMD market returns are sensible to returns on the market. As the market goes up or down, InspireMD is expected to follow. Additionally, inspireMD has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of InspireMD to move above the current price in 90 days from now is about 92.62 (This InspireMD probability density function shows the probability of InspireMD Stock to fall within a particular range of prices over 90 days) .
InspireMD Stock Institutional Holders
Institutional Holdings refers to the ownership stake in InspireMD that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of InspireMD's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing InspireMD's value.| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2023-12-31 | 28.4 K | |
| Hightower Advisors, Llc | 2023-12-31 | 27.3 K | |
| Elias Asset Management Inc | 2023-12-31 | 25 K | |
| Hollencrest Securities, Llc | 2023-12-31 | 20 K | |
| Avestar Capital, Llc | 2023-12-31 | 20 K | |
| Geode Capital Management, Llc | 2023-12-31 | 18.2 K | |
| Renaissance Technologies Corp | 2023-12-31 | 15 K | |
| Mckinley Carter Wealth Services Inc | 2024-03-31 | 10 K | |
| Advisornet Financial, Inc | 2023-12-31 | 8.8 K | |
| Nantahala Capital Management, Llc | 2023-12-31 | 4.1 M | |
| Orbimed Advisors, Llc | 2023-12-31 | 2.1 M |
InspireMD Historical Income Statement
InspireMD Income Statement is one of the three primary financial statements used for reporting InspireMD's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of InspireMD revenue and expense. InspireMD Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, InspireMD's Income Tax Expense is relatively stable compared to the past year. As of 05/03/2024, Total Other Income Expense Net is likely to grow to about 1.1 M, while Selling General Administrative is likely to drop slightly above 8 M. View More FundamentalsInspireMD Stock Against Markets
Picking the right benchmark for InspireMD stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in InspireMD stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for InspireMD is critical whether you are bullish or bearish towards InspireMD at a given time. Please also check how InspireMD's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in InspireMD without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
InspireMD Corporate Directors
InspireMD corporate directors refer to members of an InspireMD board of directors. The board of directors generally takes responsibility for the InspireMD's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of InspireMD's board members must vote for the resolution. The InspireMD board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| James Loughlin | Independent Director | Profile | |
| Campbell Rogers | Independent Director | Profile | |
| Michael Berman | Independent Director | Profile | |
| Thomas Kester | Director | Profile |
How to buy InspireMD Stock?
Before investing in InspireMD, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in InspireMD. To buy InspireMD stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of InspireMD. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase InspireMD stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located InspireMD stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased InspireMD stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as InspireMD, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy InspireMD Stock please use our How to Invest in InspireMD guide.
Already Invested in InspireMD?
The danger of trading InspireMD is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of InspireMD is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than InspireMD. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile InspireMD is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether InspireMD is a strong investment it is important to analyze InspireMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact InspireMD's future performance. For an informed investment choice regarding InspireMD Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.